Principles of Nuclear Medicine Imaging: Planar, SPECT, PET, Multi-modality, and Autoradiography Systems

The underlying principles of nuclear medicine imaging involve the use of unsealed sources of radioactivity in the form of radiopharmaceuticals. The ionizing radiations that accompany the decay of the administered radioactivity can be quantitatively detected, measured, and imaged in vivo with instruments such as gamma cameras. This paper reviews the design and operating principles, as well as the capabilities and limitations, of instruments used clinically and preclinically for in vivo radionuclide imaging. These include gamma cameras, single-photon emission computed tomography (SPECT) scanners, and positron emission tomography (PET) scanners. The technical basis of autoradiography is reviewed as well.

[1]  S. Larson,et al.  An investigation of the physical characteristics of 66Ga as an isotope for PET imaging and quantification. , 1997, Medical physics.

[2]  O. Israel,et al.  Hybrid SPECT/CT Imaging in Clinical Practice , 2006 .

[3]  Pat Zanzonico,et al.  Introduction to Clinical and Laboratory (Small-Animal) Image Registration and Fusion , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[4]  Pat Zanzonico,et al.  Routine Quality Control of Clinical Nuclear Medicine Instrumentation: A Brief Review* , 2008, Journal of Nuclear Medicine.

[5]  Pat Zanzonico,et al.  Positron emission tomography: a review of basic principles, scanner design and performance, and current systems. , 2004, Seminars in nuclear medicine.

[6]  S. Cherry,et al.  Physics in Nuclear Medicine , 2004 .

[7]  Thomas Beyer,et al.  PET/CT scanners: a hardware approach to image fusion. , 2003, Seminars in nuclear medicine.

[8]  S. Vallabhajosula.  Molecular Imaging: Radiopharmaceuticals for PET and SPECT , 2009 .

[9]  John L. Humm,et al.  From PET detectors to PET scanners , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Larson,et al.  Quantitative Imaging of Yttrium-86 with PET. The Occurrence and Correction of Anomalous Apparent Activity in High Density Regions. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[11]  P. Zanzonico.  PET-based biological imaging for radiation therapy treatment planning. , 2006, Critical reviews in eukaryotic gene expression.

[12]  Simon R Cherry,et al.  Small-animal preclinical nuclear medicine instrumentation and methodology. , 2008, Seminars in nuclear medicine.

[13]  William W. Moses.  Recent Advances and Future Advances in Time-of-Flight PET. , 2007 .

[14]  Thomas Beyer,et al.  A combined PET/CT scanner: the path to true image fusion. , 2002, The British journal of radiology.

[15]  T. Lewellen,et al.  Time-of-flight PET. , 1998, Seminars in nuclear medicine.

[16]  D W Townsend,et al.  Dual-modality PET/CT tomography for clinical oncology. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[17]  G. Molnár.  Table of isotopes, 8th edn , 1998 .

[18]  A. Brill,et al.  Radiation dosimetry and exposure in nuclear medicine. , 2008, Seminars in nuclear medicine.

[19]  Franklin C. Wong,et al.  MIRD: Radionuclide Data and Decay Schemes , 2009, Journal of Nuclear Medicine.

[20]  S. Heller,et al.  Physics, Instrumentation, and Radiation Protection , 2007 .